A Point-of-Care Measurement of NT-proBNP for Heart Failure Patients
暂无分享,去创建一个
Srinivasu Valagerahally Puttaswamy | David Steele | James McLaughlin | Sam Jeffery Fishlock | Cesar Navarro | Gennady Lubarsky | Shasidran Raj | David Steele | S. Fishlock | César Navarro | J. Mclaughlin | G. Lubarsky | S. Puttaswamy | Shasidran Raj
[1] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[2] Andreas Pahle,et al. Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study , 2018, BJGP open.
[3] Suhas S. Joshi,et al. Passive blood plasma separation at the microscale: a review of design principles and microdevices , 2015 .
[4] Vangelis Sakkalis,et al. Congestive Heart Failure Risk Assessment Monitoring through Internet of things and mobile Personal Health Systems , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[5] Amin M. Abbosh,et al. Microwave System for the Early Stage Detection of Congestive Heart Failure , 2014, IEEE Access.
[6] Michael Daniele,et al. Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP , 2018, Sensing and Bio-Sensing Research.
[7] Francesco Portaluppi,et al. Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea. , 2011, European journal of internal medicine.
[8] M.H. Baljon,et al. Evaluating connectivity for a heart failure database , 2002, Computers in Cardiology.
[9] J. Abramowitz,et al. Fear of needles and vasovagal reactions among phlebotomy patients. , 2006, Journal of anxiety disorders.
[10] I. Sarangadharan,et al. Rapid detection of NT-proBNP from whole blood using FET based biosensors for homecare , 2019, Sensors and Actuators B: Chemical.
[11] Alan S Maisel,et al. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. , 2005, American heart journal.
[12] Ian Richards,et al. Managing Heart Failure at Home With Point-of-Care Diagnostics , 2017, IEEE Journal of Translational Engineering in Health and Medicine.
[13] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[14] F. Brochard-Wyart,et al. Droplets: Capillarity and Wetting , 1999 .
[15] Jongwon Park,et al. An Optimized Colorimetric Readout Method for Lateral Flow Immunoassays , 2018, Sensors.
[16] Ana I. Barbosa,et al. Towards One-Step Quantitation of Prostate-Specific Antigen (PSA) in Microfluidic Devices: Feasibility of Optical Detection with Nanoparticle Labels , 2017, BioNanoScience.
[17] A. G. Semenov,et al. Analytical Issues with Natriuretic Peptides – has this been Overly Simplified? , 2016, EJIFCC.
[18] Shalini Prasad,et al. Nanosensor electrical immunoassay for quantitative detection of NT-pro brain natriuretic peptide. , 2013, Future cardiology.
[19] K. Nakao,et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.
[20] Fred S Apple,et al. Immunodetection of glycosylated NT-proBNP circulating in human blood. , 2008, Clinical chemistry.
[21] Juerg Schwitter,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[22] Mario Plebani,et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. , 2012, European heart journal.
[23] Barry Greenberg,et al. Primary results of the HABIT Trial (heart failure assessment with BNP in the home). , 2013, Journal of the American College of Cardiology.
[24] W Frank Peacock,et al. State of the art: Using natriuretic peptide levels in clinical practice , 2008, European journal of heart failure.
[25] Yifan Li,et al. Multi-Frequency Components Entropy as Novel Heart Rate Variability Indices in Congestive Heart Failure Assessment , 2019, IEEE Access.
[26] Juan Cinca,et al. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. , 2008, European heart journal.
[27] J. Januzzi,et al. Natriuretic peptide testing in heart failure. , 2011, Circulation.
[28] Xiaopeng Wei,et al. Predicting the Risk of Heart Failure With EHR Sequential Data Modeling , 2018, IEEE Access.
[29] A StJohn,et al. Existing and Emerging Technologies for Point-of-Care Testing. , 2014 .
[30] Li Nan,et al. Brain natriuretic peptide and optimal management of heart failure , 2005 .
[31] E. Hrncír,et al. Surface tension of blood. , 1997, Physiological research.
[32] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[33] Martin Gjoreski,et al. Machine Learning and End-to-End Deep Learning for the Detection of Chronic Heart Failure From Heart Sounds , 2020, IEEE Access.
[34] Shihui Fu,et al. Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review , 2018, Front. Physiol..
[35] W. Jian-an,et al. Brain natriuretic peptide and optimal management of heart failure , 2005, Journal of Zhejiang University Science B.
[36] Gianluigi Savarese,et al. Global Public Health Burden of Heart Failure. , 2016, Cardiac failure review.
[37] Heather R Peck,et al. A survey of apparent blood volumes and sample geometries among filter paper bloodspot samples submitted for lead screening. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[38] E. Bahadır,et al. Lateral flow assays: Principles, designs and labels , 2016 .
[39] Eric S. Nordman,et al. A Low-Cost, High-Performance System for Fluorescence Lateral Flow Assays , 2013, Biosensors.
[40] Michael J. Pencina,et al. Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease , 2015, PloS one.
[41] Hengyi Xu,et al. Development of an immunochromatographic assay for rapid and quantitative detection of clenbuterol in swine urine , 2013 .
[42] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[43] Andrew St John,et al. Existing and Emerging Technologies for Point-of-Care Testing. , 2014, The Clinical biochemist. Reviews.
[44] Gianni Tognoni,et al. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). , 2008, Journal of the American College of Cardiology.
[45] Ruo Yuan,et al. An ultrasensitive electrochemiluminescence immunosensor for NT-proBNP based on self-catalyzed luminescence emitter coupled with PdCu@carbon nanohorn hybrid. , 2017, Biosensors & bioelectronics.
[46] Claudio Passino,et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. , 2007, Clinical chemistry.
[47] Anders Larsson,et al. Specificity of B-type natriuretic peptide assays: Knockin’ on the assay door , 2017 .
[48] C. V. Van Peteghem,et al. Preliminary evaluation of a lateral flow immunoassay device for screening urine samples for the presence of sulphamethazine. , 2003, Journal of immunological methods.
[49] Xuena Zhu,et al. Paper-based Immunosensor for Oxidative DNA Damage Biomarker Detection , 2013, 2013 29th Southern Biomedical Engineering Conference.
[50] Taisun Kim,et al. Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure , 2017, Sensors.
[51] K. M. Koczula,et al. Lateral flow assays , 2016, Essays in biochemistry.
[52] A. G. Semenov,et al. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides. , 2018, Advances in clinical chemistry.
[53] C. Hamm,et al. B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide - Diagnostic role in stable coronary artery disease. , 2006, Experimental and clinical cardiology.
[54] Torben Breindahl,et al. NT-proBNP on Cobas h 232 in point-of-care testing: Performance in the primary health care versus in the hospital laboratory , 2015, Scandinavian journal of clinical and laboratory investigation.
[55] Paul Yager,et al. CO2 laser cutting and ablative etching for the fabrication of paper-based devices , 2013 .